FDA panel backs brain stimulator for epilepsy

February 25, 2013 by Barbara Bronson Gray, Healthday Reporter
FDA panel backs brain stimulator for epilepsy
Implantable device pre-empts seizures, device maker says.

(HealthDay News) - A U.S. Food and Drug Administration panel has unanimously backed a device that lowers the rate of seizures among people with epilepsy.

Smaller and thinner than an , the battery-powered, programmable device, called the RNS System, is placed just under the skull during surgery. Electrodes reach from the device to the one or two places in the patient's brain that create the that causes seizures. The device works by short-circuiting in that area to normalize before a seizure is triggered.

On Friday, the panel voted 11-0, with two members abstaining, to recommend approval of the system, according to MedPage Today. The FDA does not have to follow the recommendations of its expert panels, but it typically does.

"This is the first responsive neuro-stimulation system ever designed," said Frank Fischer, president and CEO of Mountain View Calif.-based NeuroPace Inc., which developed the device. "Our long-term results show that patients have a reduction of 50 percent or more in their , compared to baseline, and a lessening of seizure severity."

The device is designed specifically for people aged 18 and older with partial-onset epilepsy, which occurs when one or more fixed locations in a person's brain start the cascade of nerve firing that creates a seizure.

NeuroPace has done two studies involving a total of 256 patients who were monitored for a period of between two and nine years, without any significant problems, according to Fischer.

Epilepsy is a brain disorder in which a person suffers repeated seizures over time.

It affects more than 2 million Americans, according to the Epilepsy Foundation, making it the third most common in the United States, after Alzheimer's and stroke. Seizures are episodes of disturbed brain activity that cause changes in attention or behavior. keep firing instead of acting in an organized way. The malfunctioning electrical system of the brain causes surges of energy that can cause a person to have muscle contractions or to black out.

Physicians can modify the programming of the device even after it has been implanted, to reflect a patient's needs over time, Fischer said. They can also observe the brain activity of a patient from a laptop computer in their office—to help them manage a patient's treatment, he said.

Representatives of the Epilepsy Foundation said new treatments for epilepsy are sorely needed.

"We're not in a position to evaluate everything that an evaluating committee would be looking at, but we do advocate for access to treatments once they're FDA-approved," explained Angela Ostrom, vice president of public policy and advocacy for the Epilepsy Foundation, based in Landover, Md.

While Fischer said it is too soon to say what the device might cost, comparable systems for heart problems range in price from $30,000 to $35,000, not including the cost of the surgery to implant the device. The battery that powers the device lasts about three years. When it fails, a new device has to be substituted in a 30-to-60-minute outpatient surgical procedure, Fischer said.

Fischer said the company has spent 15 years developing the device.

Explore further: FDA panel to consider brain stimulator for epilepsy

More information: For more on epilepsy, see the Epilepsy Foundation .

Related Stories

FDA panel to consider brain stimulator for epilepsy

February 21, 2013

(HealthDay News) - A U.S. Food and Drug Administration advisory panel will weigh on Friday the merits of a new therapy for some people with epilepsy who have seizures that don't respond to medication.

Recommended for you

How even our brains get 'slacker' as we age

October 24, 2016

New research from Newcastle University, UK, in collaboration with the Federal University of Rio de Janeiro, investigated the way the human brain folds and how this 'cortical folding' changes with age.

How lying takes our brains down a 'slippery slope'

October 24, 2016

Telling small lies desensitises our brains to the associated negative emotions and may encourage us to tell bigger lies in future, reveals new UCL research funded by Wellcome and the Center for Advanced Hindsight.

Robotic tutors for primary school children

October 24, 2016

The use of robotic tutors in primary school classrooms is one step closer according to research recently published in the open access journal Frontiers in Computational Neuroscience.

Mouse decision-making more complex than once thought

October 24, 2016

Working with dot-counting mice running through a virtual-reality maze, scientists from Harvard Medical School have found that in order to navigate space rodent brains rely on a cascade of neural signals that culminate in ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.